Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no longer in shortage after nearly two years. Pharmacies that sold ...
PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...
The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
One main concern is to what extent insurance providers will cover such a drug, given the abundance of cheaper alternatives. The FDA has already approved more than a dozen antipsychotics for ...
The prescription drug has been all over the news in the past couple of years - but the name Ozempic has become something of a ...
Verywell Health on MSN3d
Zepbound (Tirzepatide) vs. Wegovy (Semaglutide): How Do They Compare?These drugs work similarly but differ in dosage and specific indications (uses). Research suggests that tirzepatide is more ...
The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...
The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...
Authorizing Medicare to cover weight loss drugs would increase federal spending by about $35 billion from 2026 to 2034 ...
With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...
Current health news highlights WeightWatchers offering a compound version of Novo Nordisk's obesity drug, Danco seeking FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback